Cargando…

Determination of “indeterminate score” measurements in lean nonalcoholic fatty liver disease patients from western Saudi Arabia

BACKGROUND: Noninvasive measures to estimate liver fibrosis in lieu of biopsy in nonalcoholic liver disease (NAFLD) can broadly differentiate high vs low degrees of condition extent. However, an “indeterminate score” necessitates further clinical investigation and biopsy becomes essential, highlight...

Descripción completa

Detalles Bibliográficos
Autor principal:	Khayyat, Yasir Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Observational Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727213/ https://www.ncbi.nlm.nih.gov/pubmed/35070015 http://dx.doi.org/10.4254/wjh.v13.i12.2150

Ejemplares similares

Lean non‐alcoholic fatty liver disease and associated metabolic disturbance: A Saudi Arabian cross‐sectional study
por: Khayyat, Yasir Mohammed
Publicado: (2021)

Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities
por: Miura, Kouichi, et al.
Publicado: (2022)

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
por: Kitabatake, Hiroyuki, et al.
Publicado: (2017)

Interrelationship between physical activity and depression in nonalcoholic fatty liver disease
por: Weinstein, Ali A, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
por: Dai, Yi-Ning, et al.
Publicado: (2022)

Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
por: Shengir, Mohamed, et al.
Publicado: (2020)

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
por: Khoudari, George, et al.
Publicado: (2019)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
por: Pitisuttithum, Panyavee, et al.
Publicado: (2020)

Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus
por: Yamane, Ryosuke, et al.
Publicado: (2022)

Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients
por: Zheng, Jia-Rui, et al.
Publicado: (2023)

Serologic Markers of Gluten Sensitivity in a Healthy Population from the Western Region of Saudi Arabia
por: Khayyat, Yasir M.
Publicado: (2012)

Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis
por: Damiani, Giovanni, et al.
Publicado: (2019)

Total cholesterol to high-density lipoprotein ratio and nonalcoholic fatty liver disease in a population with chronic hepatitis B
por: Zhou, Yu-Ge, et al.
Publicado: (2022)

Public awareness of colon cancer screening among the general population: A study from the Western Region of Saudi Arabia
por: Khayyat, Yasir Mohammed, et al.
Publicado: (2014)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Functional somatic illnesses in patients with functional bowel disorders: A cross-sectional cohort study in western Saudi Arabia
por: Khayyat, Yasir M.
Publicado: (2020)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Comparison of four non-alcoholic fatty liver disease detection scores in a Caucasian population
por: Lind, Lars, et al.
Publicado: (2020)

Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
por: Salgado Alvarez, Giovanni Alejandro, et al.
Publicado: (2022)

Epigenetic Regulation in Lean Nonalcoholic Fatty Liver Disease
por: Aggeletopoulou, Ioanna, et al.
Publicado: (2023)

Lean or Non-obese Nonalcoholic Fatty Liver Disease Patients: Are They Really Lean?
por: Han, Eugene, et al.
Publicado: (2023)

Prevalence of Nonalcoholic Fatty Liver Disease at a Tertiary Care Center in Saudi Arabia
por: Hussein, Ghada, et al.
Publicado: (2023)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
por: Kablawi, Dana, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean and obese patients in Saudi patients from a single center
por: Alsuhaibani, Khalid A., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Is a Risk Factor for Thiopurine Hepatotoxicity in Crohn’s Disease
por: George, Alvin T, et al.
Publicado: (2023)

Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
por: Huang, Xin-Juan, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management
por: Chrysavgis, Lampros, et al.
Publicado: (2020)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease
por: Ishido, Shun, et al.
Publicado: (2023)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
por: Alswat, Khalid, et al.
Publicado: (2018)

Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease
por: Trovato, Francesca M, et al.
Publicado: (2016)

Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease
por: Michalak, Agata, et al.
Publicado: (2022)

Erratum: Nonalcoholic fatty liver disease burden – Saudi Arabia and United Arab Emirates, 2017–2030
Publicado: (2018)

Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
por: Chun, Ho Soo, et al.
Publicado: (2023)

Prevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
por: Almeida, Naiade Silveira, et al.
Publicado: (2022)

Impact of sodium glucose cotransporter-2 inhibitors on liver steatosis/fibrosis/inflammation and redox balance in non-alcoholic fatty liver disease
por: Bellanti, Francesco, et al.
Publicado: (2022)

HOMA-IR is an effective biomarker of non-alcoholic fatty liver disease in non-diabetic population
por: Zeng, Pei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_136jc62p38neb4ugqpimh479uv